Dr Lal Pathlabs Ltd Share Price (LALPATHLAB)
₹2249.4
Dr Lal Pathlabs Ltd share Performance
- ₹2240.7₹2281₹2249.4
0.39%
Low
Day's Volatility:1.79%
High
1.40%
- ₹1881.55₹2767.1₹2249.4
16.35%
Low
52 Weeks Volatility:39.37%
High
23.02%
| Returns % | |
| 1 Month Return | -0.22 % |
| 3 Month Return | -4.57 % |
| 1 Year Return | 18.07 % |
| Market Stats | |
| Previous Close | ₹2,262.60 |
| Open | ₹2,281.00 |
| Volume | 1.75L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹18,887.70Cr |
Analyst Rating for Dr Lal Pathlabs Ltd stock
based on 19 analysts
Based on 19 analysts offering long term price targets for Dr Lal Pathlabs Ltd. An average target of ₹2442.89
Source: S&P Global Market Intelligence
Company Information
The company's top products include pathology tests, imaging tests, and preventive health check-ups. Its popular brands include Dr Lal PathLabs, Lal PathLabs, and Lal PathLabs Diagnostics. Dr Lal PathLabs Ltd has over 2000 labs across India, with more than 2000 collection centers, and over 20000 trained professionals. The company is also present in Nepal, Sri Lanka, and Bangladesh.
Dr Lal PathLabs Ltd is committed to providing quality healthcare services and products to its customers. It is ISO 9001:2015 certified and has been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
Share Price: ₹2249.40 per share as on 23 Apr, 2024 04:01 PM
Market Capitalisation: ₹18,887.70Cr as of today
Revenue: ₹538.90Cr as on December 2023 (Q4 23)
Net Profit: ₹82.20Cr as on December 2023 (Q4 23)
Listing date: 23 Dec, 2015
Chairperson Name: Arvind Lal
| Organisation | Dr Lal Pathlabs Ltd |
| Headquarters | Gurgaon |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Dr Lal Pathlabs Ltd
Online Diagnostic Firms Threaten Offline Players - 22 Apr, 2024
Dr Lal PathLabs and Metropolis Healthcare are facing competition from online diagnostic players like Tata 1mg and Healthians, who are expanding offline in north India. Hospitals have also expanded their offline outlets at a slower pace.
Dr Lal Pathlabs ROCE Falls to 22% - 13 Apr, 2024
Dr. Lal PathLabs has an ROCE of 22%, outpacing the industry average but down from 29% five years ago. While reinvesting for growth, it may take time before earnings improve. The stock has delivered a 130% gain over five years.
Dr Lal Pathlabs Stock Gains Over 3% - 12 Apr, 2024
Dr Lal Pathlabs Ltd's stock gained over 3% to reach Rs.2,381.80 with a significant increase in trading volume on the BSE.
Diagnostic Companies to Register 10-11% Growth in Revenue by FY2025 - 10 Apr, 2024
A study by CRISIL predicts that diagnostic companies, including Dr Lal PathLabs, are set to register a growth of 10-11% in revenue by financial year 2025 due to an increase in patients and improving revenue per patient.
BNP Paribas Gives Buy Call on Dr Lal Pathlabs with Target Price of Rs 3181 - 05 Apr, 2024
BNP Paribas has given a buy call on Dr Lal Pathlabs with a target price of Rs 3181. The company reported a consolidated total income of Rs 557.20 crore for the quarter ended December 31, 2023, and net profit after tax of Rs 82.20 crore. Promoters hold 54.6% stake in the company.
Dr Lal PathLabs Upgraded by Kotak Institutional Equities - 26 Mar, 2024
Kotak Institutional Equities has double upgraded Dr Lal PathLabs from Sell to Add with an increased fair value of ₹2,360. The revised price target implies a potential upside of 8% from last Friday's closing levels.
Fundamentals of Dr Lal Pathlabs Ltd
Insights on Dr Lal Pathlabs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 5.88% to 6.79% in Mar 2024 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 25.35% to 26.15% in Mar 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Global Health Ltd has given 190.9% return, outperforming this stock by 172.8%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 54.60% of holdings in Mar 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 237.7% return, outperforming this stock by 259.3%
NEGATIVE IMPACTPrice Dip
In the last 3 years, LALPATHLAB stock has moved down by -21.6%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 619.4 Cr → 557.2 Cr (in ₹), with an average decrease of 10.0% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 10.12% to 9.24% in Mar 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 109.3 Cr → 81.3 Cr (in ₹), with an average decrease of 25.6% per quarter
Dr Lal Pathlabs Ltd Valuation
Dr Lal Pathlabs Ltd in the last 5 years
Lowest (37.51x)
November 16, 2018
Today (56.96x)
April 22, 2024
Industry (92.08x)
April 22, 2024
Highest (95.62x)
November 5, 2020
Mutual Fund Holdings
| Funds | Holdings |
 UTI Flexi Cap Fund - Growth Option - Direct | 1.49% |
 SBI Large & Midcap Fund Direct Growth | 0.69% |
| UTI Mid Cap Fund-Growth Option- Direct | 1.21% |
 PGIM India Midcap Opportunities Fund Direct Growth | 0.89% |
 Kotak Equity Arbitrage Fund Direct Growth | 0.18% |
Shareholding Pattern
| Investors | Holdings % | Prev. 1 periods | 3M change |
|---|---|---|---|
| Promoter Holdings | 54.6% | 0.00 | |
| Foreign Institutions | 26.15% | 0.00 | |
| Mutual Funds | 6.79% | 0.00 | |
| Retail Investors | 9.24% | 0.00 | |
| Others | 3.21% | 0.00 |
Technicals of Dr Lal Pathlabs Ltd share
News & Events of Dr Lal Pathlabs Ltd
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Dr Lal Pathlabs Ltd shares.
Dr Lal Pathlabs Ltd (LALPATHLAB) share price today is ₹2249.4
Dr Lal Pathlabs Ltd is listed on NSE
Dr Lal Pathlabs Ltd is listed on BSE
- Today’s highest price of Dr Lal Pathlabs Ltd is ₹2281.
- Today’s lowest price of Dr Lal Pathlabs Ltd is ₹2240.7.
PE Ratio of Dr Lal Pathlabs Ltd is 56.96
PE ratio = Dr Lal Pathlabs Ltd Market price per share / Dr Lal Pathlabs Ltd Earnings per share
Today’s traded volume of Dr Lal Pathlabs Ltd(LALPATHLAB) is 1.75L.
Today’s market capitalisation of Dr Lal Pathlabs Ltd(LALPATHLAB) is ₹18887.7Cr.
| Dr Lal Pathlabs Ltd(LALPATHLAB | Price |
|---|---|
52 Week High | ₹2767.1 |
52 Week Low | ₹1881.55 |
Dr Lal Pathlabs Ltd(LALPATHLAB) share price is ₹2249.4. It is down -18.71% from its 52 Week High price of ₹2767.1
Dr Lal Pathlabs Ltd(LALPATHLAB) share price is ₹2249.4. It is up 19.55% from its 52 Week Low price of ₹1881.55
| Dr Lal Pathlabs Ltd(LALPATHLAB | Returns |
|---|---|
1 Day Returns | -13.2% |
1 Month Returns | -0.22% |
3 Month Returns | -4.57% |
1 Year Returns | 18.07% |